alert graphic is a stylized exclamation mark

Please carefully review our COVID-19 information hub for updates on IRB processes during the COVID-19 outbreak.

Skip to end of metadata
Go to start of metadata

IRB information regarding COVID-19

The guidelines below apply ONLY to studies overseen by the NIH IRB.  If the study is overseen by a non-NIH IRB, you must follow the policies of that IRB.

For all sponsored studies, you must receive sponsor approval for any changes to the protocol.

March 11, 2020

NIH IRB Guidelines for protocol deviations during COVID-19 outbreak

March 12, 2020

Instructions to be followed for treating a patient with a study drug at a non-study location

March 30, 2020

IRB continued operations and facilitation of the rapid review of any human subjects research related to the SARS-CoV-2 pandemic.

March 31, 2020

OHSRP Procedures Related to COVID-19 Research and the PREP Act

April 7, 2020

Important information regarding COVID-19 related research

July 13, 2020

Informed Consent During the COVID-19 Outbreak